Recent Updates
Recently added Catalysts
TMO Positive Sentiment

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026

Monday, September 28, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Thermo Fisher Scientific Inc. will announce its financial results for Q3 2026 before the market opens on October 21, 2026. A conference call is scheduled for the same day at 7:00 a.m. ET, where the company will discuss its financial performance and future expectations. The call will be available via live webcast.

Market Sentiment Analysis

POSITIVE FACTORS

  • Thermo Fisher Scientific is releasing its Q3 2026 financial results.
  • The company is hosting a conference call to discuss performance and future expectations.
  • The event is accessible via a live webcast, enhancing investor engagement.

Full Press Release Details

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2026 before the market opens on Wednesday, October 21, 2026, and will hold a conference call on the same day at 7:00 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the “Investors” section of our website, www.thermof

Frequently Asked Questions

When will Thermo Fisher release its Q3 2026 financial results?

Thermo Fisher will release its Q3 2026 financial results on October 21, 2026.

What time is the earnings conference call scheduled?

The earnings conference call is scheduled for 7:00 a.m. ET on October 21, 2026.

How can investors access the conference call?

Investors can access the conference call via a live webcast on the company's website.

What will be discussed during the conference call?

The conference call will cover Thermo Fisher's financial performance and future expectations.

ShareAdd on Google
Tags: TMO Viatris Investor Conferences Healthcare Thermo Fisher earnings call Q3 2026 financial results
Last updated: Sep 28, 2026

Biotech snapshot

Cash runway
$4064M liquidity · $0M/mo burn
Low dilution risk